U.S. markets open in 7 hours 12 minutes

KraneShares MSCI All China Health Care Index ETF (KURE)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
38.60+0.02 (+0.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close38.58
Bid0.00 x 1000
Ask0.00 x 1000
Day's Range38.34 - 38.89
52 Week Range24.80 - 47.69
Avg. Volume145,498
Net Assets238.19M
PE Ratio (TTM)N/A
YTD Daily Total Return-0.90%
Beta (5Y Monthly)0.63
Expense Ratio (net)0.65%
Inception Date2018-01-31
  • Best Pharmaceutical ETFs for Q2 2021

    Best Pharmaceutical ETFs for Q2 2021

    Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.

  • ETF.com

    COVID Impact Varies Across Emerging Market ETFs

    Emerging markets have been hit hard by coronavirus, but some were hit harder than others.

  • KraneShares Launches Krane All China Growth Strategy Model
    PR Newswire

    KraneShares Launches Krane All China Growth Strategy Model

    KraneShares, a global asset management firm known for its China-focused exchange-traded funds (ETFs) and innovative China investment strategies, today announced the launch of the Krane All China Growth Strategy. The model seeks to provide investors exposure to the brightest high-growth areas within China's economy. Specifically, the model will include China's rapidly growing internet and healthcare sectors, as well as the exact Mainland China A-Share securities being added into MSCI's Emerging Markets Index, tracked by $1.5 trillion in assets.1